February 21, 2024 · Form 4 insider transaction
King Michael bought 115,000 shares of SAB Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents options to purchase shares of common stock pursuant to the Company's 2014 Equity Incentive Plan.; The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.